
Michael B. Pallay
Examiner (ID: 6707, Phone: (571)270-3473 , Office: P/1617 )
| Most Active Art Unit | 1617 |
| Art Unit(s) | 1617 |
| Total Applications | 911 |
| Issued Applications | 439 |
| Pending Applications | 108 |
| Abandoned Applications | 384 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18418491
[patent_doc_number] => 20230172949
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-08
[patent_title] => THERMO-KINETIC MIXING FOR PHARMACEUTICAL APPLICATIONS
[patent_app_type] => utility
[patent_app_number] => 17/814567
[patent_app_country] => US
[patent_app_date] => 2022-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20182
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17814567
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/814567 | Thermo-kinetic mixing for pharmaceutical applications | Jul 24, 2022 | Issued |
Array
(
[id] => 19431037
[patent_doc_number] => 20240299535
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-12
[patent_title] => TARGETED GLYCOSAMINOGLYCAN-PARTICLES AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 18/579096
[patent_app_country] => US
[patent_app_date] => 2022-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16803
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18579096
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/579096 | TARGETED GLYCOSAMINOGLYCAN-PARTICLES AND METHODS OF USE | Jul 12, 2022 | Pending |
Array
(
[id] => 17880397
[patent_doc_number] => 20220295874
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-22
[patent_title] => ORAL PRODUCT WITH SUSTAINED FLAVOR RELEASE
[patent_app_type] => utility
[patent_app_number] => 17/834994
[patent_app_country] => US
[patent_app_date] => 2022-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21219
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17834994
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/834994 | ORAL PRODUCT WITH SUSTAINED FLAVOR RELEASE | Jun 7, 2022 | Pending |
Array
(
[id] => 18160804
[patent_doc_number] => 20230027396
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-26
[patent_title] => EXCIPIENT COMPOUNDS FOR BIOPOLYMER FORMULATIONS
[patent_app_type] => utility
[patent_app_number] => 17/825027
[patent_app_country] => US
[patent_app_date] => 2022-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32613
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17825027
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/825027 | EXCIPIENT COMPOUNDS FOR BIOPOLYMER FORMULATIONS | May 25, 2022 | Abandoned |
Array
(
[id] => 19279799
[patent_doc_number] => 20240216271
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-04
[patent_title] => HYDROLYTICALLY DEGRADABLE HYDROGELS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/563543
[patent_app_country] => US
[patent_app_date] => 2022-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21817
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18563543
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/563543 | HYDROLYTICALLY DEGRADABLE HYDROGELS AND USES THEREOF | May 25, 2022 | Pending |
Array
(
[id] => 20142276
[patent_doc_number] => 12376589
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-08-05
[patent_title] => Chryseobacterium insect inhibitory microbial compositions and methods of making and using
[patent_app_type] => utility
[patent_app_number] => 17/724078
[patent_app_country] => US
[patent_app_date] => 2022-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 36
[patent_no_of_words] => 18354
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17724078
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/724078 | Chryseobacterium insect inhibitory microbial compositions and methods of making and using | Apr 18, 2022 | Issued |
Array
(
[id] => 19256822
[patent_doc_number] => 12016851
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-06-25
[patent_title] => Modified release pharmaceutical formulations comprising deferiprone
[patent_app_type] => utility
[patent_app_number] => 17/717922
[patent_app_country] => US
[patent_app_date] => 2022-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 9816
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 195
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17717922
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/717922 | Modified release pharmaceutical formulations comprising deferiprone | Apr 10, 2022 | Issued |
Array
(
[id] => 19256821
[patent_doc_number] => 12016850
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-06-25
[patent_title] => Modified release pharmaceutical formulations comprising deferiprone
[patent_app_type] => utility
[patent_app_number] => 17/717913
[patent_app_country] => US
[patent_app_date] => 2022-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 11731
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 181
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17717913
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/717913 | Modified release pharmaceutical formulations comprising deferiprone | Apr 10, 2022 | Issued |
Array
(
[id] => 17748102
[patent_doc_number] => 20220226305
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-21
[patent_title] => METHOD AND COMBINATION FOR TREATING VIRAL INFECTION AND LONG HAULER SYNDROME
[patent_app_type] => utility
[patent_app_number] => 17/714760
[patent_app_country] => US
[patent_app_date] => 2022-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17964
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17714760
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/714760 | METHOD AND COMBINATION FOR TREATING VIRAL INFECTION AND LONG HAULER SYNDROME | Apr 5, 2022 | Pending |
Array
(
[id] => 18055496
[patent_doc_number] => 20220386582
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-08
[patent_title] => METHOD AND DEVICE TO TRAP ACARIDS
[patent_app_type] => utility
[patent_app_number] => 17/702731
[patent_app_country] => US
[patent_app_date] => 2022-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13483
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17702731
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/702731 | METHOD AND DEVICE TO TRAP ACARIDS | Mar 22, 2022 | Abandoned |
Array
(
[id] => 19248555
[patent_doc_number] => 20240199542
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-20
[patent_title] => SUBSTITUTED PYRROLIDIN-2-ONES, SALTS THEREOF AND THEIR USE AS HERBICIDALLY ACTIVE SUBSTANCES
[patent_app_type] => utility
[patent_app_number] => 18/551766
[patent_app_country] => US
[patent_app_date] => 2022-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 56932
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18551766
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/551766 | SUBSTITUTED PYRROLIDIN-2-ONES, SALTS THEREOF AND THEIR USE AS HERBICIDALLY ACTIVE SUBSTANCES | Mar 17, 2022 | Pending |
Array
(
[id] => 19048539
[patent_doc_number] => 20240090508
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-21
[patent_title] => NOVEL ANTIMICROBIAL COMPOSITION OF CARBOXYLIC ACIDS WITH ALDEHYDE AND ANTIOXIDANTS COMBINATION
[patent_app_type] => utility
[patent_app_number] => 18/282346
[patent_app_country] => US
[patent_app_date] => 2022-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3503
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18282346
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/282346 | NOVEL ANTIMICROBIAL COMPOSITION OF CARBOXYLIC ACIDS WITH ALDEHYDE AND ANTIOXIDANTS COMBINATION | Mar 15, 2022 | Pending |
Array
(
[id] => 17702762
[patent_doc_number] => 20220202768
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-30
[patent_title] => DIHYDROMYRICETIN NANOEMULSION FORMULATIONS AND METHODS FOR FORMING THEM
[patent_app_type] => utility
[patent_app_number] => 17/694571
[patent_app_country] => US
[patent_app_date] => 2022-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20054
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -33
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17694571
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/694571 | DIHYDROMYRICETIN NANOEMULSION FORMULATIONS AND METHODS FOR FORMING THEM | Mar 13, 2022 | Abandoned |
Array
(
[id] => 18107194
[patent_doc_number] => 20230000074
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-05
[patent_title] => SPRAYABLE MICROENCAPSULATED PHEROMONES
[patent_app_type] => utility
[patent_app_number] => 17/678966
[patent_app_country] => US
[patent_app_date] => 2022-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13937
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -40
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17678966
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/678966 | SPRAYABLE MICROENCAPSULATED PHEROMONES | Feb 22, 2022 | Pending |
Array
(
[id] => 20156647
[patent_doc_number] => 12383243
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-08-12
[patent_title] => Extracellular matrix (ECM) hydrogel as a submucosal fluid cushion
[patent_app_type] => utility
[patent_app_number] => 17/581591
[patent_app_country] => US
[patent_app_date] => 2022-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 14
[patent_no_of_words] => 8376
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 151
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17581591
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/581591 | Extracellular matrix (ECM) hydrogel as a submucosal fluid cushion | Jan 20, 2022 | Issued |
Array
(
[id] => 17576771
[patent_doc_number] => 20220133626
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-05
[patent_title] => TOPICAL COMPOSITIONS AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/578669
[patent_app_country] => US
[patent_app_date] => 2022-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36728
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17578669
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/578669 | TOPICAL COMPOSITIONS AND METHODS OF USE THEREOF | Jan 18, 2022 | Abandoned |
Array
(
[id] => 20401184
[patent_doc_number] => 12491143
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-12-09
[patent_title] => Compositions and methods for the treatment of cellulite
[patent_app_type] => utility
[patent_app_number] => 17/576694
[patent_app_country] => US
[patent_app_date] => 2022-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3408
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17576694
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/576694 | Compositions and methods for the treatment of cellulite | Jan 13, 2022 | Issued |
Array
(
[id] => 17702749
[patent_doc_number] => 20220202755
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-30
[patent_title] => FORMULATIONS OF L-ORNITHINE PHENYLACETATE
[patent_app_type] => utility
[patent_app_number] => 17/570253
[patent_app_country] => US
[patent_app_date] => 2022-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8798
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17570253
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/570253 | FORMULATIONS OF L-ORNITHINE PHENYLACETATE | Jan 5, 2022 | Abandoned |
Array
(
[id] => 17561670
[patent_doc_number] => 20220125819
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-28
[patent_title] => METHODS OF PREVENTING AND TREATING COVID-19 INFECTION
[patent_app_type] => utility
[patent_app_number] => 17/568452
[patent_app_country] => US
[patent_app_date] => 2022-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11324
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17568452
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/568452 | METHODS OF PREVENTING AND TREATING COVID-19 INFECTION | Jan 3, 2022 | Abandoned |
Array
(
[id] => 19049364
[patent_doc_number] => 20240091333
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-21
[patent_title] => Temperature Stable Nucleic Acid Method for Preparing Vaccines
[patent_app_type] => utility
[patent_app_number] => 18/269925
[patent_app_country] => US
[patent_app_date] => 2021-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6368
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18269925
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/269925 | Temperature Stable Nucleic Acid Method for Preparing Vaccines | Dec 27, 2021 | Pending |